List of Tables
Table 1. Microbiome Therapeutics Market Trends
Table 2. Microbiome Therapeutics Market Drivers & Opportunity
Table 3. Microbiome Therapeutics Market Challenges
Table 4. Microbiome Therapeutics Market Restraints
Table 5. Global Microbiome Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Microbiome Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Microbiome Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Microbiome Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Microbiome Therapeutics
Table 10. Global Microbiome Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Microbiome Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Microbiome Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Microbiome Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Microbiome Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Microbiome Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Microbiome Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Microbiome Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Microbiome Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Microbiome Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Microbiome Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Microbiome Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Microbiome Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Microbiome Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Microbiome Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Microbiome Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Microbiome Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Microbiome Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Microbiome Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Seres Therapeutics Basic Information List
Table 32. Seres Therapeutics Description and Business Overview
Table 33. Seres Therapeutics Microbiome Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Microbiome Therapeutics Business of Seres Therapeutics (2019-2024)
Table 35. Seres Therapeutics Recent Developments
Table 36. Assembly Biosciences Basic Information List
Table 37. Assembly Biosciences Description and Business Overview
Table 38. Assembly Biosciences Microbiome Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Microbiome Therapeutics Business of Assembly Biosciences (2019-2024)
Table 40. Assembly Biosciences Recent Developments
Table 41. Synthetic Biologics Basic Information List
Table 42. Synthetic Biologics Description and Business Overview
Table 43. Synthetic Biologics Microbiome Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Microbiome Therapeutics Business of Synthetic Biologics (2019-2024)
Table 45. Synthetic Biologics Recent Developments
Table 46. Interxon Basic Information List
Table 47. Interxon Description and Business Overview
Table 48. Interxon Microbiome Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Microbiome Therapeutics Business of Interxon (2019-2024)
Table 50. Interxon Recent Developments
Table 51. PureTech Basic Information List
Table 52. PureTech Description and Business Overview
Table 53. PureTech Microbiome Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Microbiome Therapeutics Business of PureTech (2019-2024)
Table 55. PureTech Recent Developments
Table 56. Synlogic Basic Information List
Table 57. Synlogic Description and Business Overview
Table 58. Synlogic Microbiome Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Microbiome Therapeutics Business of Synlogic (2019-2024)
Table 60. Synlogic Recent Developments
Table 61. Enterome BioScience Basic Information List
Table 62. Enterome BioScience Description and Business Overview
Table 63. Enterome BioScience Microbiome Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Microbiome Therapeutics Business of Enterome BioScience (2019-2024)
Table 65. Enterome BioScience Recent Developments
Table 66. 4D Pharma Basic Information List
Table 67. 4D Pharma Description and Business Overview
Table 68. 4D Pharma Microbiome Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Microbiome Therapeutics Business of 4D Pharma (2019-2024)
Table 70. 4D Pharma Recent Developments
Table 71. Second Genome Basic Information List
Table 72. Second Genome Description and Business Overview
Table 73. Second Genome Microbiome Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Microbiome Therapeutics Business of Second Genome (2019-2024)
Table 75. Second Genome Recent Developments
Table 76. AOBiome Basic Information List
Table 77. AOBiome Description and Business Overview
Table 78. AOBiome Microbiome Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Microbiome Therapeutics Business of AOBiome (2019-2024)
Table 80. AOBiome Recent Developments
Table 81. C3 Jian Basic Information List
Table 82. C3 Jian Description and Business Overview
Table 83. C3 Jian Microbiome Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Microbiome Therapeutics Business of C3 Jian (2019-2024)
Table 85. C3 Jian Recent Developments
Table 86. Rebiotix Basic Information List
Table 87. Rebiotix Description and Business Overview
Table 88. Rebiotix Microbiome Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Microbiome Therapeutics Business of Rebiotix (2019-2024)
Table 90. Rebiotix Recent Developments
Table 91. MicroBiome Therapeutics LLC Basic Information List
Table 92. MicroBiome Therapeutics LLC Description and Business Overview
Table 93. MicroBiome Therapeutics LLC Microbiome Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Microbiome Therapeutics Business of MicroBiome Therapeutics LLC (2019-2024)
Table 95. MicroBiome Therapeutics LLC Recent Developments
Table 96. Metabiomics Basic Information List
Table 97. Metabiomics Description and Business Overview
Table 98. Metabiomics Microbiome Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Microbiome Therapeutics Business of Metabiomics (2019-2024)
Table 100. Metabiomics Recent Developments
Table 101. Ritter Pharmaceuticals Basic Information List
Table 102. Ritter Pharmaceuticals Description and Business Overview
Table 103. Ritter Pharmaceuticals Microbiome Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Microbiome Therapeutics Business of Ritter Pharmaceuticals (2019-2024)
Table 105. Ritter Pharmaceuticals Recent Developments
Table 106. Symberix Basic Information List
Table 107. Symberix Description and Business Overview
Table 108. Symberix Microbiome Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Microbiome Therapeutics Business of Symberix (2019-2024)
Table 110. Symberix Recent Developments
Table 111. OpenBiome Basic Information List
Table 112. OpenBiome Description and Business Overview
Table 113. OpenBiome Microbiome Therapeutics Products, Services and Solutions
Table 114. Revenue (US$ Million) in Microbiome Therapeutics Business of OpenBiome (2019-2024)
Table 115. OpenBiome Recent Developments
Table 116. Azitra Basic Information List
Table 117. Azitra Description and Business Overview
Table 118. Azitra Microbiome Therapeutics Products, Services and Solutions
Table 119. Revenue (US$ Million) in Microbiome Therapeutics Business of Azitra (2019-2024)
Table 120. Azitra Recent Developments
Table 121. Symbiotix Biotherapies Basic Information List
Table 122. Symbiotix Biotherapies Description and Business Overview
Table 123. Symbiotix Biotherapies Microbiome Therapeutics Products, Services and Solutions
Table 124. Revenue (US$ Million) in Microbiome Therapeutics Business of Symbiotix Biotherapies (2019-2024)
Table 125. Symbiotix Biotherapies Recent Developments
Table 126. Osel Basic Information List
Table 127. Osel Description and Business Overview
Table 128. Osel Microbiome Therapeutics Products, Services and Solutions
Table 129. Revenue (US$ Million) in Microbiome Therapeutics Business of Osel (2019-2024)
Table 130. Osel Recent Developments
Table 131. Metabogen Basic Information List
Table 132. Metabogen Description and Business Overview
Table 133. Metabogen Microbiome Therapeutics Products, Services and Solutions
Table 134. Revenue (US$ Million) in Microbiome Therapeutics Business of Metabogen (2019-2024)
Table 135. Metabogen Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Microbiome Therapeutics Downstream Customers
Table 139. Microbiome Therapeutics Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Microbiome Therapeutics Product Picture
Figure 2. Global Microbiome Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Microbiome Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Microbiome Therapeutics Report Years Considered
Figure 5. Global Microbiome Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Microbiome Therapeutics Revenue in 2023
Figure 7. Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Upper GIT Picture
Figure 9. Lower GIT Picture
Figure 10. Global Microbiome Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Microbiome Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of C. difficile Infection (CDI)
Figure 13. Product Picture of Inflammatory Bowel Disease (IBD)
Figure 14. Product Picture of Orphan Drug
Figure 15. Product Picture of Immuno-oncology
Figure 16. Product Picture of Others
Figure 17. Global Microbiome Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Microbiome Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Microbiome Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Microbiome Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Microbiome Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Microbiome Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Microbiome Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Microbiome Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Microbiome Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Microbiome Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Microbiome Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Microbiome Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Microbiome Therapeutics Sales Value (%), (2019-2030)
Figure 30. United States Microbiome Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Microbiome Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Microbiome Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Microbiome Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Microbiome Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Microbiome Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 36. China Microbiome Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Microbiome Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 38. China Microbiome Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Microbiome Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Microbiome Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Microbiome Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Microbiome Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Microbiome Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Microbiome Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Microbiome Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Microbiome Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Microbiome Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 48. India Microbiome Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Microbiome Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 50. India Microbiome Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 51. Microbiome Therapeutics Industrial Chain
Figure 52. Microbiome Therapeutics Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
